Accurate reporting of CFTR mutations is of clinical interest in improving genetic screening techniques, understanding CF genotype-phenotype correlations, and treatments of individuals affected with CF, non-classic CF, or CFTR-related disorders (CFTR-RD). The gene discussed is CFTR; the disease is cystic fibrosis.